R&D | pharmaphorum

Wednesday 1 April 2026

R&D

News

There are three types of white blood cells. T lymphocytes, B lymphocytes and natural killer cells.

Implants could transform CAR-T therapy into one-day procedur...

CAR-T therapies have revolutionised the treatment of some blood cancers, but are costly as well as time- and resource-intensive.

Events

Advancing Engineered, Native & Bispecific TCRs to Effectively Treat Solid Tumors

Partner Content

TCR-based Therapeutics for Solid Tumors Summit

Hear from experts at the TCR based Therapeutics Summit

Events

ARDS Pharmaphorum Banners

Partner Content

2nd ARDS Drug Development Summit

Only Industry-Specific Event for ARDS Drug Developers

Events

GDT Pharmaphorum Banners

Partner Content

3rd Gamma Delta T Therapies Summit

The Only Industry-Specific Event on γδT Therapies

Events

BT Cell Pharmaphorum Banners

Partner Content

3rd B & T Cell-Mediated Autoimmune Disease Drug Development ...

Industry-led forum focused on B & T Cell Collaboration

News

Merck&Co_photo

Merck turns to cardiovascular pipeline for its post-Keytruda...

For some years industry observers have been asking what Merck & Co can do to reduce its reliance on blockbuster cancer immunotherapy Keytruda.